Key facts
- This page summarizes Naiem Hussain's Form 4 filing for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Feb 2024, 19:30.
Naiem Hussain - 15 Feb 2024 Form 4 Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ADN
- Reported as of
- 15 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Feb 2024, 19:30:48 UTC
- Prior SEC filing
- 12 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Naiem Hussain
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Naiem Hussain filed Form 4 for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN) on 20 Feb 2024.
Change
- Previous filing in this sequence was filed on 12 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +166,779
- Change %
- +196%
- Price
- $0.000000
- Shares after
- 251,779
- Date
- 15 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ADN
transaction
Derivative
Employee stock options (right to buy)
Award
- Transaction value
- $0
- Shares
- +166,779
- Change %
- Price
- $0.000000
- Shares after
- 166,779
- Date
- 15 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 166,779
- Exercise price
- $0.1650
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Restricted stock units ("RSUs") representing a contingent right to receive common stock, granted pursuant to Issuer's 2021 Equity Incentive Plan, dated February 4, 2021 (the "Plan").
Footnote F2
RSUs are a common stock equivalent that may be settled solely by delivery of an equal number of shares of Issuer's common stock. They vest 25% on each anniversary of the grant date and will be fully vested on February 15, 2028.
Footnote F3
Received pursuant to the Plan. The options will vest 25% upon each anniversary of February 15, 2024, the vesting commencement date, until the fourth anniversary of the vesting commencement date on February 15, 2028.